KORU Medical Systems Inc Overview
Industry: Healthcare Equipment & Supplies
Sector: Healthcare
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the subcutaneous drug delivery market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. The company was incorporated in 1980 and is headquartered in Mahwah, New Jersey. KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the subcutaneous drug delivery market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver Read MoreMavefund brings filings, fundamentals, valuation, price history and news for KORU Medical Systems Inc into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $11.8M (+22% YoY); EPS was $2,026 (+2025% YoY).
Revenue
$11.8M
+22% YoY
EPS
$2,026
+2025% YoY
Net loss
-$807.1M
-31% YoY
Cash
$8.8M
reported
What changed
- Revenue +22% YoY to $11.8M; EPS +2025% YoY to $2,026.
- Net loss -31% YoY to -$807.1M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
FORM 10-Q QUARTERLY REPORT FOR 03-31-2026
May 06, 2026
SEC filing
FORM 8-K CURRENT REPORT FOR 05-06-2026
May 06, 2026
Earnings release
PRESS RELEASE, DATED MARCH 12, 2026
Mar 12, 2026
SEC filing
FORM 8-K CURRENT REPORT FOR 03-12-2026
Mar 12, 2026
SEC filing
FORM 10-K ANNUAL REPORT FOR 12-31-2025
Mar 12, 2026
SEC filing
FORM 8-K CURRENT REPORT FOR 01-12-2026
Jan 12, 2026
Earnings release
PRESS RELEASE, DATED JANUARY 12, 2026
Jan 12, 2026
SEC filing
FORM 10-Q QUARTERLY REPORT FOR 09-30-2025
Nov 12, 2025
SEC filing
FORM 8-K CURRENT REPORT FOR 11-12-2025
Nov 12, 2025
Earnings release
PRESS RELEASE, DATED NOVEMBER 12, 2025
Nov 12, 2025
SEC filing
FORM 10-Q QUARTERLY REPORT FOR 06-30-2025
Aug 06, 2025
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Form 4 KORU Medical Systems Inc For: 13 July By Investing.com
Headline from Investing.com Canada: Form 4 KORU Medical Systems Inc For: 13 July By Investing.com.
Earnings Per Share
Score 1.00/5
KORU Medical Systems Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Healthcare Equipment & Supplies industry
, AmerisourceBergen
, Insulet Corporation
, NuVasive Inc
are companies with high ratings.
Return on Equity
Score 1.91/5
KORU Medical Systems Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Score 2.05/5
KORU Medical Systems Inc
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Score 3.12/5
KORU Medical Systems Inc
attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
, also exhibit high scores.
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios